Cisplatin Interactions
There are 461 drugs known to interact with cisplatin, along with 7 disease interactions. Of the total drug interactions, 89 are major, 353 are moderate, and 19 are minor.
- View all 461 medications that may interact with cisplatin
- View cisplatin disease interactions (7)
Most frequently checked interactions
View interaction reports for cisplatin and the medicines listed below.
- Adriamycin (doxorubicin)
- Adriamycin (doxorubicin)
- Ativan (lorazepam)
- Ativan (lorazepam)
- Avastin (bevacizumab)
- Avastin (bevacizumab)
- Compazine (prochlorperazine)
- Compazine (prochlorperazine)
- Cytoxan (cyclophosphamide)
- Cytoxan (cyclophosphamide)
- Decadron (dexamethasone)
- Decadron (dexamethasone)
- Gemzar (gemcitabine)
- Gemzar (gemcitabine)
- Metoprolol Succinate ER (metoprolol)
- Metoprolol Succinate ER (metoprolol)
- Quercetin (bioflavonoids)
- Quercetin (bioflavonoids)
- Taxol (paclitaxel)
- Taxol (paclitaxel)
- Tylenol (acetaminophen)
- Tylenol (acetaminophen)
- Vitamin B12 (cyanocobalamin)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Vitamin D3 (cholecalciferol)
- Zofran (ondansetron)
- Zofran (ondansetron)
Cisplatin disease interactions
There are 7 disease interactions with cisplatin which include:
- infections
- hearing loss
- myelosuppression
- peripheral neuropathy
- renal dysfunction
- hemolytic anemia
- ocular toxicity
More about cisplatin
- cisplatin consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: alkylating agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Loqtorzi
Loqtorzi (toripalimab-tpzi) is a PD-1 inhibitor medicine used for the treatment of advanced ...
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Rybrevant
Rybrevant is used to treat certain types of non-small cell lung cancer (NSCLC) in adults. It is ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Diflucan
Diflucan (fluconazole) is used to treat and prevent fungal infections. Includes Diflucan side ...
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Fluorouracil
Fluorouracil systemic is used for anal cancer, breast cancer, breast cancer, palliative, cancer ...
Pembrolizumab
Pembrolizumab (Keytruda) is a monoclonal antibody cancer medicine used to treat
Carboplatin
Carboplatin is used alone or in combination with other medications to treat ovarian cancer. Learn ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.